Cellular DNA and nuclear proteins (DNA)

Cellular DNA and nuclear proteins represent the collective genetic and structural components within the cell nucleus that govern heredity, gene expression, and cellular replication. DNA serves as the primary template for life, while nuclear proteins such as histones, topoisomerases, and transcription factors regulate its accessibility and integrity (Source: NIH/NCBI). In clinical pharmacology, this complex is a major target for traditional cytotoxic chemotherapies, which aim to disrupt the rapid proliferation of malignant cells by inducing DNA damage or inhibiting essential nuclear processes (Source: PubMed). Mechanisms include the formation of DNA adducts, interstrand cross-links, and the stabilization of cleavage complexes, ultimately triggering apoptosis (Source: StatPearls). However, because these targets are fundamental to all dividing cells, therapeutic intervention often results in significant systemic toxicity and long-term safety concerns such as secondary cancers (Source: American Cancer Society). Modern drug development has shifted towards more specific inhibitors of DNA repair proteins and epigenetic modifiers to improve the therapeutic index.

Other names

Genomic DNANuclear DNAChromatinDeoxyribonucleic acid

Drugs targeting cellular DNA and nuclear proteins act through various mechanisms including DNA alkylation, intercalation, cross-linking, and inhibition of enzymes like topoisomerases or polymerases to disrupt replication and transcription.